Exicure(us:XCUR)
18.67
+18.61%
Updated on 2024-12-22
Open:16.91
Close:18.67
High:19.50
Low:16.23
Pre Close:15.74
Volume:222813.00
Amount:4.06M
Turnover:8.55%
Shares:2.61M
MarketCap:48.65M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 22 | 536788 | 6.20% | 2 | 2 | 10 |
| 2024-03-31 | 20 | 630562 | 7.29% | 4 | 8 | 3 |
| 2023-12-31 | 20 | 587113 | 6.79% | 3 | 2 | 10 |
| 2023-09-30 | 17 | 656226 | 7.59% | 2 | 7 | 5 |
| 2023-06-30 | 16 | 652806 | 7.55% | 1 | 3 | 7 |
| 2023-03-31 | 17 | 684927 | 8.18% | 2 | 3 | 7 |
| 2022-12-31 | 19 | 782220 | 15.75% | 2 | 4 | 6 |
| 2022-09-30 | 22 | 718663 | 14.48% | 4 | 4 | 11 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Carlyle Group Inc. | 281636 | 3.26% | 0 | |
| 2024-03-31 | Renaissance Technologies Llc | 65600 | 0.76% | 16100 | 32.52% |
| 2024-03-31 | Geode Capital Management, Llc | 56519 | 0.65% | 3523 | 6.65% |
| 2024-03-31 | Northwestern University | 52145 | 0.60% | 0 | |
| 2024-03-31 | Vanguard Group Inc | 40093 | 0.46% | 0 | |
| 2024-03-31 | Millennium Management Llc | 34801 | 0.40% | -23014 | -39.81% |
| 2024-03-31 | Virtu Financial Llc | 27043 | 0.31% | 8369 | 44.82% |
| 2024-03-31 | Two Sigma Securities, Llc | 22698 | 0.26% | 5972 | 35.70% |
| 2024-03-31 | Citadel Advisors Llc | 18159 | 0.21% | 18159 | |
| 2024-03-31 | Bank Of America Corp /De/ | 12800 | 0.15% | 12800 |
About
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Address:2430 North Halsted Street
Website:http://www.exicuretx.com
Market Movers